Genetics: What advice for patients who present with a family history of melanoma?

被引:15
作者
Bishop, Julia A. Newton [1 ]
Gruis, Nelleke A. [2 ]
机构
[1] St James Hosp, Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds LS9 7TF, W Yorkshire, England
[2] Leiden Univ, Med Ctr, Skin Res Lab, Leiden, Netherlands
关键词
D O I
10.1053/j.seminoncol.2007.09.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A significantly increased susceptibility to melanoma may manifest as a family history of melanoma (plus or minus pancreatic cancer), the development of multiple primary tumors, or melanoma in the context of numerous and clinically atypical moles (the atypical mole syndrome). In families, increased susceptibility may occur as a result of the inheritance of mutations at the CDKN2A locus or in the CDK4 gene. We describe what is known about these genes and discuss the implications for genetic counseling and gene testing. Lower levels of risk are associated with genetically determined pigmentary variation within populations. This variation is attributable to inheritance of variants in the MC1R gene and putatively other genes such as OCA2, which is discussed. Melanoma is causally related to sun exposure in the majority of patients, although the patterns of sun exposure, which are most important, remain controversial. The role of risk estimation for individuals in giving advice about sun exposure is considered.
引用
收藏
页码:452 / 459
页数:8
相关论文
共 82 条
[1]   HETEROGENEITY OF MELANOMA RISK IN FAMILIES OF MELANOMA PATIENTS [J].
AITKEN, JF ;
DUFFY, DL ;
GREEN, A ;
YOUL, P ;
MACLENNAN, R ;
MARTIN, NG .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (11) :961-973
[2]   Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi [J].
Annessi, G ;
Cattaruzza, MS ;
Abeni, D ;
Baliva, G ;
Laurenza, M ;
Macchini, V ;
Melchi, F ;
Ruatti, P ;
Puddu, P ;
Faraggiana, T .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (01) :77-85
[3]  
AZIZI E, 1995, CANCER, V76, P1571, DOI 10.1002/1097-0142(19951101)76:9<1571::AID-CNCR2820760912>3.0.CO
[4]  
2-6
[5]  
Bahuau M, 1998, CANCER RES, V58, P2298
[6]   MAPPING THE GENE FOR HEREDITARY CUTANEOUS MALIGNANT-MELANOMA DYSPLASTIC NEVUS TO CHROMOSOME-1P [J].
BALE, SJ ;
DRACOPOLI, NC ;
TUCKER, MA ;
CLARK, WH ;
FRASER, MC ;
STANGER, BZ ;
GREEN, P ;
DONISKELLER, H ;
HOUSMAN, DE ;
GREENE, MH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21) :1367-1372
[7]   Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse [J].
Bardeesy, N ;
Aguirre, AJ ;
Chu, GC ;
Cheng, KH ;
Lopez, LV ;
Hezel, AF ;
Feng, B ;
Brennan, C ;
Weissleder, R ;
Mahmood, U ;
Hanahan, D ;
Redston, MS ;
Chin, L ;
DePinho, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (15) :5947-5952
[8]   Linkage and association analysis of nevus density and the region containing the melanoma gene CDKN2A in UK twins [J].
Barrett, JH ;
Gaut, R ;
Wachsmuth, R ;
Bishop, JAN ;
Bishop, DT .
BRITISH JOURNAL OF CANCER, 2003, 88 (12) :1920-1924
[9]   The melanocortin-1-receptor gene is the major freckle gene [J].
Bastiaens, M ;
ter Huurne, J ;
Gruis, N ;
Bergman, W ;
Westendorp, R ;
Vermeer, BJ ;
Bavinck, JNB .
HUMAN MOLECULAR GENETICS, 2001, 10 (16) :1701-1708
[10]   Genetics of risk factors for melanoma: An adult twin study of nevi and freckles [J].
Bataille, V ;
Snieder, H ;
MacGregor, AJ ;
Sasieni, P ;
Spector, TD .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (06) :457-463